Russell Investments Group, Ltd. Aquestive Therapeutics, Inc. Transaction History
Russell Investments Group, Ltd.
- $84.2 Billion
- Q3 2025
A detailed history of Russell Investments Group, Ltd. transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 163,385 shares of AQST stock, worth $880,645. This represents 0.0% of its overall portfolio holdings.
Number of Shares
163,385
Previous 127,704
27.94%
Holding current value
$880,645
Previous $422,000
116.35%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding AQST
# of Institutions
172Shares Held
66.2MCall Options Held
794KPut Options Held
457K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$52.9 Million100.0% of portfolio
-
Rtw Investments, LP New York, NY6.25MShares$33.7 Million0.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.66MShares$30.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$29.4 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.76MShares$20.3 Million0.05% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $288M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...